Press Releases

December 13, 2022
Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration
November 28, 2022
Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting
November 28, 2022
Praxis Precision Medicines to Advance PRAX-562 Phase 2 Study in Pediatric Patients with Developmental and Epileptic Encephalopathies
November 9, 2022
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
September 21, 2022
Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference
September 20, 2022
Invitae’s Real-World Ciitizen Data Utilized in Praxis Precision Medicines’ PRAX-222 IND Filing
September 7, 2022
Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 7, 2022
Praxis Precision Medicines Provides Updates on Clinical Stage Pediatric Epilepsy Programs
August 8, 2022
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Displaying 1 - 10 of 26